REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/19/2025
Back to search
Official data from USPTO
FAZACLO (CLOZAPINE, USP) ORALLY DISINTEGRATING TABLETS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
09/20/2025
Trademark type
Combined
Nice classes
5
Filing date
04/30/2004
Registration date
09/19/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/17/2016
Last transaction
09/20/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/31/2004
First use in commerce
07/31/2004
Drawing code
3
Owner type
11
Owner location
DUBLIN, IE
Examiner
THOMPSON, HEATHER
Law office
L90
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the word "FazaClo" in a stylized format, above the words "clozapine, USP," in parenthesis, in a stylized format, above the words "Orally Disintegrating Tablets" in a stylized format; to the left of and beside "FazaClo" and "(clozapine, USP)" and above "Orally Disintegrating Tablet" appears a stylized 16 point starburst represented by a series of spheres with the largest sphere in the center surrounded by successively smaller spheres that eventually decrease in dimension to form the 16 points of the starburst.
Holders and representatives
Holders
JAZZ PHARMACEUTICALS IRELAND LIMITED
JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
AZUR PHARMA INTERNATIONAL III LIMITED
Alamo Pharmaceuticals, LLC
Representatives
Timothy D. Sitzmann Winthrop & Weinstine, P.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of schizophrenia
Publications
History of USPTO decisions and trademark events.
47 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/26/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/24/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/15/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/15/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/17/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/17/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/17/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/17/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
08/03/2016
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/19/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/22/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/24/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/26/2014
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/29/2012
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/29/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/29/2012
E815
TEAS SECTION 8 & 15 RECEIVED
09/24/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/26/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/21/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/21/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/09/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/03/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/03/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/02/2007
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
08/04/2006
ALIE
ASSIGNED TO LIE
07/28/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/25/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/19/2006
IUAF
USE AMENDMENT FILED
06/27/2006
EISU
TEAS STATEMENT OF USE RECEIVED
06/27/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/27/2005
PUBO
PUBLISHED FOR OPPOSITION
10/04/2005
NPUB
NOTICE OF PUBLICATION
09/14/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/17/2005
ALIE
ASSIGNED TO LIE
06/10/2005
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/07/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/26/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/19/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/19/2005
GNRT
NON-FINAL ACTION E-MAILED
11/29/2004
CNRT
NON-FINAL ACTION WRITTEN
11/29/2004
DOCK
ASSIGNED TO EXAMINER
11/29/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2004
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/04/2004
NWAP
NEW APPLICATION ENTERED
05/07/2004
Continuous trademark protection
Get notified about every new filing that threatens FAZACLO (CLOZAPINE, USP) ORALLY DISINTEGRATING TABLETS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.